DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20173977

Clinico-microbiological analysis of bactibilia isolates in patients of cholecystectomy

Ashima Katyal, Kiran Bala, Anand Bansal, Uma Chaudhary

Abstract


Background: The current study determined microbial flora in bile aspirates from patients undergoing cholecystectomy along with antibiotic susceptibility pattern and resistance mechanism viz. extended spectrum β-lactamase (ESBL).

Methods: The study included 110 such patients which were divided in three groups as: Group A that included acute cholecystitis with or without cholelithiasis, Group B included chronic cholecystitis with or without cholelithiasis and Group C included other hepatobiliary ailments requiring cholecystectomy viz. gallbladder carcinoma, acute emphysematous gall bladder and mucocele gall bladder. The bile was subjected to complete microbiological and histopathological examination. Antimicrobial susceptibility of the isolates was performed as per CLSI guidelines.

Results: Bacteria were recovered from 07 samples (20%) in Group A, 17 (48.57%) in Group B and 11 (31.43%) in Group C. The polymicrobial infection was seen in 04 (11.43%) patients. The most common organisms isolated were Escherichia coli 15 (38.46%), Klebsiella pneumoniae and Pseudomonas aeruginosa 8 (20.51% each). The majority of Enterobacteriaceae isolates were susceptible to piperacillin-tazobactam and carbapenems. The ESBL production was observed in 17 (43.58%) isolates.

Conclusions: Therefore, antimicrobial susceptibility of potential causative organisms, presence of resistant strains in bile, the severity of the cholecystitis, and the local susceptibility pattern must be taken into consideration while prescribing antibiotics. A protocol regarding the management of such cases should be formulated based on observations of similar studies.

 


Keywords


Acute and chronic cholecystitis, Bactibilia, ESBL, Gallbladder carcinoma

Full Text:

PDF

References


Williams NS, Bulstrode CJK, O’Connell PR. The gall bladder and bile ducts. In: Williams NS, Bulstrode CJK, O’Connell PR. Bailey and Love’s short practice of surgery. 25th ed. London: Hodder Arnold; 2008:1111-29.

Kapoor VK, McMichael AJ. Gallbladder cancer: an ‘Indian’ disease. Nat Med J India. 2003;16(4):209-13.

Pitchumoni CS. Increasing prevalence of gallstones; diagnostic and therapeutic options. In: Rao MR. Association of Physician, India, Medicine update. Mumbai: Urvi Compugraphics; 2010:486-90.

Manan F, Khan MA, Faraz A, Khan M. Frequency of common bacteria and their antibiotic sensitivity in patients with symptomatic cholelithiasis. J Postgrad Med Inst. 2014;28(2):177-83

Capoor MR, Nair D, Rajni, Khanna G, Krishna SV, Chintamani MS, et al. Microflora of bile aspirates in patients with acute cholecystitis with or without cholelithiases: a tropical experience. Braz J Inf Dis. 2008;12(3):222-5.

Shoda J, Tanaka N, Osuga T. Hepatolithiasis: epidemiology and pathogenesis update. Front Biosci. 2003;8:e398-409.

Lammert F, Matern S. The genetic background of cholesterol gallstone formation: an inventory of human lithogenic genes. Curr Drug Targets Immune Endocr Metabol Disord. 2005;5:163-70.

Flemma RJ, Flint LM, Osterhout S, Shingelton WW. Bacteriologic studies of biliary tract infection. Annals Surg. 1967;166(4):563-70.

Greenberger NJ, Paumgartner G. Diseases of gallbladder and bile ducts. In: Kasper DL, Fauci AS, Hauser SL, Longo DL, Jameson JL, Loscalzo J. Harrison’s Principles of Internal Medicine. 19th ed. New York: McGraw-Hill; 2015:2075-2086.

Ebert EC, Nagar M, Hagspiel KD. Gastrointestinal and hepatic complications of sickle cell disease. Clin Gastroenterol Hepatol. 2010;8:483-9.

Abeysuriya V, Deen KI, Wijesuriya T, Salgado SS. Microbiology of gallbladder bile in uncomplicated symptomatic cholelithiases. Hepatobiliary Pancreat Dis Int. 2008;7:633-7.

Burke MD, Kennedy AS, Katz J, Movsas B, Talavera F, McKenna R. Gallbladder cancer. Medscape. 2017. Available at http://www.emedicine.medscape.com/article/27861.

Afamefuna S, Allen SN. Pathophysiology, diagnosis and treatment: gallbladder disease. US Pharmacist. 2013;38(3):33-41.

Bistgani MM, Imani R. Bile bacteria of patients with cholelithiases and theirs antibiogram. Acta Medica Iranica. 2013;51(11):779-83.

Paterson DL, Ko WC, Von Gottberg A, Mohapatra S, Casellas JM, Goossens H, et al. International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial Infections. Ann Intern Med. 2004;140:26-32.

Chang WT, Chuang SC, Lee KT. The impact of prophylactic antibiotics on postoperative infection complication in elective laparoscopic cholecystectomy: a prospective randomized study. Am J Surg. 2006;191(6):721-5.

Kim HJ, Park JH, Park DI, Cho YK, Shon CI, Jeon WK et al. Clinical impact of Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in patients with biliary tract infection. Digest Dis Sci. 2013;58(3):841-9.